
Regulatory approval granted for United Airlines $100 million investment in Azul
Source link
Pfizer Inc. (PFE) Announces FDA Priority Review Grant for HYMPAVZI® (marstacimab) sBLA
Pfizer Inc. (NYSE:PFE) is one of the the best healthcare stocks under $50 to invest. Pfizer Inc. (NYSE:PFE) announced on February 6 that the US Food and Drug Administration has…






